DE2022117B2 - Powdery starting mixture for the production of bone cement with the addition of methyl methacrylate - Google Patents

Powdery starting mixture for the production of bone cement with the addition of methyl methacrylate

Info

Publication number
DE2022117B2
DE2022117B2 DE19702022117 DE2022117A DE2022117B2 DE 2022117 B2 DE2022117 B2 DE 2022117B2 DE 19702022117 DE19702022117 DE 19702022117 DE 2022117 A DE2022117 A DE 2022117A DE 2022117 B2 DE2022117 B2 DE 2022117B2
Authority
DE
Germany
Prior art keywords
bone cement
antibiotic
infection
bone
addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19702022117
Other languages
German (de)
Other versions
DE2022117C3 (en
DE2022117A1 (en
Inventor
Gerd R. Dr.Med. 8000 Muenchen Hessert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD International Holdings GmbH
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Priority to DE19702022117 priority Critical patent/DE2022117C3/en
Priority to GB1344571A priority patent/GB1349259A/en
Publication of DE2022117A1 publication Critical patent/DE2022117A1/en
Publication of DE2022117B2 publication Critical patent/DE2022117B2/en
Application granted granted Critical
Publication of DE2022117C3 publication Critical patent/DE2022117C3/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F265/00Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00
    • C08F265/04Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated monocarboxylic acids or derivatives thereof as defined in group C08F20/00 on to polymers of esters
    • C08F265/06Polymerisation of acrylate or methacrylate esters on to polymers thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • A61L24/0015Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)

Claims (1)

Patentanspruch:Claim: Pulverförmige Ausgangsmischung für die unter Methacrylsäuremethylester-Zusatz erfolgende Herstellung von Knochenzement, bestehend aus PoIymethacrylsäuremethylester und Gentamycin.Powdered starting mixture for the under Methacrylic acid methyl ester addition taking place of bone cement, consisting of polymethacrylic acid methyl ester and gentamycin. Die Erfindung betrifft eine pulverförmige Ausgangsmischung für die unter Metharcrylsäuremethylester-Zusatz erfolgende Herstellung von Knochenzement.The invention relates to a powdery starting mixture for the addition of methyl methacrylate subsequent production of bone cement. Es ist bekannt, Fremdkörperimplantate, wie künstliche Gelenke, mit diesen zugeordneten und diese erhaltenden Knochen dadurch zu verbinden, daß pulverförmiger polymerer Methacrylsäuremethylester zu einer knetbaren Substanz vermischt und unter Polymerisation des Monomers aushärten gelassen wird.It is known to have foreign body implants, such as artificial joints, associated with them and these to connect the preserving bone in that powdered polymeric methyl methacrylate mixed into a kneadable substance and allowed to harden with polymerization of the monomer. Dieser bekannte Knochenzement weist den Nachteil auf, daß er nicht in der Lage ist, in seinem Bereich, insbesondere an seinen Randzonen auftretende Infektionen zu verhindern bzw. zu bekämpfen. Es hat sich jedoch gezeigt, daß trotz gewissenhafter Einhaltung der Asepsis derartige Infektionen verhältnismäßig häufig auftreten. Eine solche Infektion kann beispielsweise von außen erfolgen durch den Keimgehalt der Luft, durch das Durchwanderungsvermögen von Keimen vom Körper des Operateurs, durch seine Operationskleidung oder durch Keime, die dem Patienten außerhalb des desinfizierten Bereichs anhaften. Außerdem kann eine Inf'.k". :on an einem Implantat von innen her beispielsweise durch eine hämatogene Streuung aus dem Operationsgebiet benachbarten Infektionsherden herrühren, die bei der Voruntersuchung verborgen geblieben sind.This known bone cement has the disadvantage that it is not able to, in its area, in particular to prevent or combat infections occurring at its edge zones. It has however, it has been shown that, despite conscientious observance of asepsis, such infections are relatively common appear. Such an infection can for example take place from the outside through the germ content of the air the ability of germs to migrate from the surgeon's body through his surgical clothing or by germs adhering to the patient outside the disinfected area. In addition, a Inf'.k ".: On an implant from the inside, for example originate from a hematogenous spread from neighboring foci of infection in the operating area, which remained hidden during the preliminary examination. Während das Behandlungsziel bei stabilisierenden Osteosythesekörpern wie Nägeln oder Platten selbst nach erfolgter Infektion noch erreicht werden kann, da diese Fremdkörper regelmäßig wieder aus dem Körper entfernt werden, so daß eine direkte Behandlung des Infektionsherdes möglich ist. kann das Bchandlungszicl bei infizierten Implantaten regelmäßig nicht erreicht werden. Dies ist zumindest dann der Fall, wenn der Infektionsherd bis an das Implantat heranreicht. In derartigen Fällen können regelmäßig auch Abhilfsmittel wie Spüldrainagen oder/und eine hohe Dosierung pharmazeutischer Mitlei in Tablettenform bzw. Injektionen keine wirksame Abhilfe schaffen. Vielmehr muß das Implantat bei derartigen Infektionen wieder entfernt werden. Ein solcher Eingriff bedeutet jedoch nicht nut einen Mißerfolg der Operation, sondern hat häufig Beschädigungen an den Verbindungsstellen zwischen dem Implantat und mit diesem verbundenen Knochen zur Folge.While the goal of treatment is stabilizing osteosynthesis bodies such as nails or plates themselves can still be reached after infection, since these foreign bodies are regularly removed from the body removed so that direct treatment of the source of infection is possible. can the Bchandlungszicl regularly cannot be achieved with infected implants. This is at least the case when the The source of the infection reaches up to the implant. In such cases, remedies can also be used regularly such as irrigation drainages and / or a high dosage of pharmaceutical ingredients in tablet form or injections does not provide an effective remedy. Rather, the implant must be restored in the event of such infections removed. Such an intervention does not only mean a failure of the operation, but has often damage to the connection points between the implant and associated therewith Result in bones. Der gleiche Nachteil ergibt sich, wenn der bekannte Knochenzement zur Deckung von Knochendefekten, d. h. zur Ausfüllung fehlender Knochensubstanz, mit einem tragenden Material verwand! wird.The same disadvantage arises when the known bone cement is used to cover bone defects, d. H. used to fill in missing bone substance with a load-bearing material! will. Der Erfindung liegt die Aufgabe zugrunde, den bekannten Knochenzement unter Vermeidung der vorgenannten Nachteile dahingehend zu verbessern, daß die mit bekannten Mitteln nicht wirksam zu bekämpfende Infektionen nicht auftreten bzw. wenn dieses dennoch der Fall sein sollte, am Ort ihresThe invention is based on the object to improve known bone cement while avoiding the aforementioned disadvantages, that the infections that cannot be effectively combated with known agents do not occur or if this should nevertheless be the case, at the place of yours Entstehens wirksam bekämpft werden können. DabeiArising can be combated effectively. Included soll insbesondere der Bereich an der Oberfläche des eingebrachten Knochenzements, d. h. der Bereich zwischen dem Knochenzement und dem Implantat bzw. dem Knochenzement und dem Knochen sowie den jeweils angrenzenden Weichteilen vor einer solchenin particular, the area on the surface of the introduced bone cement, d. H. the area between the bone cement and the implant or the bone cement and the bone and the adjacent soft tissues in front of such Infektion freigehalten werden.Infection to be kept free. Diese Aufgabe wird erfindungsgemäß durch eineAccording to the invention, this object is achieved by a ίο pulverförmige Ausgangsmischung für die unter Methacrylsäuremethylester-Zusatz erfolgende Herstellung von Knochenzement, bestehend aus Polmethacrylsäuremeihylester und Gentamycin, gelöstίο Powdery starting mixture for those with the addition of methyl methacrylate subsequent production of bone cement, consisting of methyl methacrylate and gentamicin, dissolved Es wurde nämlich im Hemmhoftest nachgewiesen,It was proven in the inhibition test daß der aus der erfindungsgemäßen Ausgangsnvschung hergestellte Knochenzement das Wachstum und die Vitalität von Bakterien in einem solchen Maße beeinflußt, daß bei Infektionen an Implantaten oder bei der Deckung von Knoehendefekten keinerlei operative Mißerfolge zu erwarten sind, da eine etwa außerhalb des Bereichs des Knochenzements auftretende Infektion in bekannter Weise zu bekämpfen ist. D;e erfindungsgemäße Ausgangsmischutig ergibt somit einen Knochenzement, der ein außerordentlich wirksames Depot des Antibiotikums darstellt, das bei seiner Verwendung zwangsläufig an den kritischen Stellen vorhanden ist.that the bone cement produced from the starting material according to the invention supports the growth and the The vitality of bacteria is influenced to such an extent that in the case of infections on implants or in the coverage of knee defects no surgical operation Failures are to be expected, since an infection occurring approximately outside the area of the bone cement in is known to be combated. The initial mixture according to the invention thus results in a bone cement, which is an extremely effective depot of the antibiotic that comes with its use is inevitably present at the critical points. Zwar ist die Verwendung von Heilstoffen in Kunststoffen, wie Polyurethanprothesen, bekannt (DE-AS 12 72 488). Hieraus war jedoch für den Fachmann nicht die erfindungsgemäße Ausgangsmischung abzuleiten, da diese sowohl hinsichtlich der Auswahl des Kunststoffs als auch hinsichtlich der Wahl des Antibiotikums eine optimale zuerst schnellere und dann über einen lanzen Zeitraum anhaltende Abgabe des Antibiotikums icherstellt. Andere Antibiotika werden gar nicht (Tetracyclin) oder nur geringfügig bzw. weniger lange anhaltend abgegeben oder sind aus anderen Gründen, insbesondere wegen des Wirkungsspektrums oder der Verträglichkeit, ungeeignet, obwohl gerade Tetracyclin bereits in einem Zahnzement aufThe use of healing substances in plastics, such as polyurethane prostheses, is known (DE-AS 12 72 488). For the person skilled in the art, however, this did not result in the starting mixture according to the invention derive, as this is both in terms of the choice of plastic and in terms of choice of the antibiotic an optimal release that is first faster and then sustained over a long period of time of the antibiotic i created. Other antibiotics do not work at all (tetracycline) or only slightly or given off for a shorter period of time or are unsuitable for other reasons, in particular because of the spectrum of activity or tolerability, although Tetracycline is already present in a dental cement Methacrylsäurebasis vorgeschlagen worden war (TheMethacrylic acid base had been proposed (The journal of the American Dental Association Bd. 47, 1953,Seiten 524-531).journal of the American Dental Association Vol. 47, 1953, pp. 524-531). Bei der Herstellung des Knochenzements wird dasDuring the production of the bone cement, the pulverförmige Polymer vor dem Vermischen mit dem flüssigen Monomer mit dem pulverförmigen Antibiotikum vermischt. Es hat sich gezeigt, daß die Festigkeitswerte des erhaltenen Knochenzements gegenüber dem bekannten Knochenzement durch Gentamycinzusatz keine Verschlechterung aufweisen. Als besonderer Vorteil der Erfindung hat sich gezeigt, daß die Depotwirkung des Antibiotikums über einen längeren Zeitraum gegeben ist, der etwa mit dem Zeitraum übereinstimmt, in dem erfahrungsgemäß Infektionen der genannten Art auftreten können. Der Knochenzement geht dabei noch über die Wirkung eines beispielsweise injizierten Antibiotikums hinaus, da dieses bekanntlich nach einer gewissen Zeit aus dem Körper wieder ausgeschieden bzw. im Körper abgebaut wird, wobei diese Ausscheidungs- bzw. Abbauzeit geringer ist als die Zeit, in der das Antibiotikumdepot des aus der erfindungsgemäßen Aus^angsmischung zur Herstellung eines Knochenzements abgegebenen Gentamycins wirksam ist.powdered polymer prior to mixing with the liquid monomer with the powdered antibiotic mixed. It has been shown that the strength values of the bone cement obtained compared to known bone cement show no deterioration due to the addition of gentamicin. As a special one The advantage of the invention has been shown that the depot effect of the antibiotic over a longer period A period of time is given which roughly coincides with the period in which, experience has shown, infections of the type mentioned can occur. The bone cement goes beyond the effect of a For example, injected antibiotic addition, as this is known to be from the after a certain time Body is excreted or broken down in the body, this time being excretion or breakdown is less than the time in which the antibiotic depot of the starting mixture according to the invention for Manufacture of a bone cement given off gentamycin is effective.
DE19702022117 1970-05-06 1970-05-06 Powdered starting mixture for the production of bone cement with the addition of methyl methacrylate Expired DE2022117C3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE19702022117 DE2022117C3 (en) 1970-05-06 1970-05-06 Powdered starting mixture for the production of bone cement with the addition of methyl methacrylate
GB1344571A GB1349259A (en) 1970-05-06 1971-05-06 Adhesive cement and method for its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702022117 DE2022117C3 (en) 1970-05-06 1970-05-06 Powdered starting mixture for the production of bone cement with the addition of methyl methacrylate

Publications (3)

Publication Number Publication Date
DE2022117A1 DE2022117A1 (en) 1971-11-25
DE2022117B2 true DE2022117B2 (en) 1980-04-17
DE2022117C3 DE2022117C3 (en) 1980-12-11

Family

ID=5770368

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702022117 Expired DE2022117C3 (en) 1970-05-06 1970-05-06 Powdered starting mixture for the production of bone cement with the addition of methyl methacrylate

Country Status (2)

Country Link
DE (1) DE2022117C3 (en)
GB (1) GB1349259A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3314977A1 (en) * 1983-04-26 1984-10-31 ESPE Fabrik pharmazeutischer Präparate GmbH, 8031 Seefeld USE OF DIFUNCTIONAL ACRYLIC ACID AND METHACRYLIC ACID ESTERS FOR THE PRODUCTION OF CURABLE BONE CEMENTS

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2511122B2 (en) * 1975-03-14 1977-06-08 PRE-PRODUCT FOR THE PREPARATION OF BONE CEMENT
DE2552070C3 (en) * 1975-11-20 1981-06-19 Beiersdorf Ag, 2000 Hamburg Process for the production of a mass which can be used for surgical purposes
DE2651441A1 (en) * 1976-11-11 1978-05-24 Merck Patent Gmbh Compsn. contg. polyacrylate or polymethacrylate and antibiotic - with aminoacid added to control antibiotic release, esp. useful as cements in bone surgery
DE2724814C3 (en) * 1977-06-02 1980-03-27 Kulzer & Co Gmbh, 6380 Bad Homburg Preliminary product for the preparation of bone cement
FR2478650A1 (en) * 1980-03-24 1981-09-25 Commissariat Energie Atomique CEMENT FOR USE IN FIXING BONE PROSTHESES
DE3133016A1 (en) * 1981-08-20 1983-03-10 Mundipharma GmbH, 6250 Limburg Process for the production of a tricalcium phosphate bone ceramic for use as bone implant, in particular for filling in cavities or for fixing bone fragments after fractures, and tricalcium phosphate ceramic moulding produced thereby
US5258420A (en) * 1987-07-30 1993-11-02 Pfizer Hospital Products Group, Inc. Bone cement for sustained release of substances
US4900546A (en) * 1987-07-30 1990-02-13 Pfizer Hospital Products Group, Inc. Bone cement for sustained release of substances
DE3738422A1 (en) * 1987-11-12 1989-05-24 Beiersdorf Ag SURGICAL MATERIAL
US4837279A (en) * 1988-02-22 1989-06-06 Pfizer Hospital Products Corp, Inc. Bone cement
DE4433201A1 (en) * 1994-09-17 1996-03-21 Merck Patent Gmbh Process for the production of active ingredient-containing bone cements
DE19511663A1 (en) * 1995-03-30 1996-10-02 Merck Patent Gmbh Middle refractive optical layers
DE102004049121B4 (en) * 2004-10-07 2008-01-10 Heraeus Kulzer Gmbh Antibiotic / antibiotics containing PMMA bone cement

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3314977A1 (en) * 1983-04-26 1984-10-31 ESPE Fabrik pharmazeutischer Präparate GmbH, 8031 Seefeld USE OF DIFUNCTIONAL ACRYLIC ACID AND METHACRYLIC ACID ESTERS FOR THE PRODUCTION OF CURABLE BONE CEMENTS

Also Published As

Publication number Publication date
GB1349259A (en) 1974-04-03
DE2022117C3 (en) 1980-12-11
DE2022117A1 (en) 1971-11-25

Similar Documents

Publication Publication Date Title
DE2320373C3 (en)
DE69826451T2 (en) Anesthetic bone cement
DE60111068T2 (en) POLYMIC ADMINISTRATION OF LEUPROLIDE WITH IMPROVED EFFICACY
DE19953771C1 (en) Absorbable bone implant material and method for producing the same
DE2657370C2 (en) Means for covering and / or filling in bone defects
EP0701824B1 (en) Method of preparing bone cements containing active agents
DE2022117C3 (en) Powdered starting mixture for the production of bone cement with the addition of methyl methacrylate
EP1112095B1 (en) Biologically active implants
EP0973561B1 (en) Bone cement paste containing an antibiotic
CH634228A5 (en) METHOD FOR PRODUCING A NEW ANTIBIOTIC CONTAINER FROM PLASTIC PARTICLES.
DE2158226A1 (en) MEDICINAL INGREDIENTS CARRIER MADE OF SILICONE RUBBER
DE2844960A1 (en) USE OF MOLDABLE THERMOPLASTIC POLYMERIZES FOR FASTENING PROSTHESES TO BONES
EP0920341A1 (en) Process for producing bone cement containing active substances
EP0413171A1 (en) Strong analgesic composition and process for its preparation
DE60027209T2 (en) Treatment of bone tissue diseases
DE3124981A1 (en) ACTIVE INGREDIENT COLLAGEN INSERT FOR INSERTION INTO BONES OR SOFT PARTS AND METHOD FOR THEIR PRODUCTION
EP0023994B1 (en) Dental medicinal root filling paste
DE19620117C1 (en) Preparation of medicinal composition containing calcium sulphate
DE3704047C2 (en)
DE69925064T2 (en) Device for introducing antibiotic powders into the femoral canal
DE3005350A1 (en) GRAINER CERAMIC CARRIER FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS AND MEDICINAL PRODUCTS INCLUDED IN THEM
DE2756256A1 (en) Compsn. for treating bone defects - comprises gellable soln. of polysaccharide and/or gelatin
CH643732A5 (en) Aid for covering and/or filling bone defects and process for the production thereof
EP1305055B1 (en) Modular implant system containing active substances and method for the production thereof
DE2651441A1 (en) Compsn. contg. polyacrylate or polymethacrylate and antibiotic - with aminoacid added to control antibiotic release, esp. useful as cements in bone surgery

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8228 New agent

Free format text: BERENDT, T., DIPL.-CHEM. DR., PAT.-ANW., 8000 MUENCHEN

8327 Change in the person/name/address of the patent owner

Owner name: TECHNOBIOTIC LTD., LUZERN, CH